Does Medicare Cover Cannabis Australia? 2026 Complete Guide

The Critical Distinction: Medicare vs PBS (Why This Confusion Exists)

Before addressing costs, it's crucial to understand the common misconception: Medicare and the PBS are not the same thing. This confusion is widespread, even among healthcare providers, and explains why you may receive mixed messages about coverage.

What Medicare Actually Covers

Medicare is Australia's universal healthcare system that covers:

• Doctor consultations: If your GP or specialist prescribes medicinal cannabis, you can claim the Medicare rebate for that consultation (typically $35–$85 depending on the provider)
• Hospital services: Public hospital care if you're admitted for complications
• Pharmaceutical Benefits Scheme (PBS): Medicare administers the PBS, but medicinal cannabis is explicitly excluded from PBS listing

What the PBS Covers (and Why Cannabis Is Excluded)

The Pharmaceutical Benefits Scheme is the federal government program that subsidises approved medications. As of 2026, medicinal cannabis products are not listed on the PBS because:

1. Regulatory pathway: Most medicinal cannabis is prescribed under the TGA's Special Access Scheme (SAS) or Authorised Prescriber (AP) programs, not as standard PBS-listed medicines
2. Clinical evidence requirements: The Pharmaceutical Benefits Advisory Committee (PBAC) has not yet recommended PBS listing for broad medicinal cannabis indications, though reviews are ongoing for specific conditions like epilepsy and chemotherapy-induced nausea
3. Cost-effectiveness concerns: Government assessments continue to evaluate whether subsidising cannabis offers value compared to existing treatments

2026 Cost Breakdown: What Australian Patients Actually Pay

Since Medicare doesn't subsidise the medication itself, Australian patients face significant out-of-pocket costs. Here's the current 2026 pricing landscape:

Monthly Medication Costs (2026 Data)

Product Type	2026 Average Cost (Monthly)	Notes
Pharmaceutical-grade capsules/oils (e.g., Epidyolex, Nabiximols)	$200–$600	Prescription-only, TGA-approved
Special Access Scheme (SAS) products	$150–$400	Individual patient prescriptions
Authorised Prescriber products	$180–$450	Recurring prescriptions from specialists
Low-dose CBD (Pharmacist-only)	$60–$120	Available without prescription in some states

Additional Costs to Consider

• Prescription fees: $30–$80 per script (not covered by Medicare)
• Private pathology tests: Some insurers require baseline blood work ($100–$300)
• Specialist consultations: $150–$400 if your GP refers you (partial Medicare rebate may apply)

2026 Market Trends

Prices have stabilised compared to 2024–2025 due to increased domestic production and competition. The Australian medicinal cannabis market reached $350 million in 2025, with wholesale prices dropping 15–20% year-on-year, though retail prices remain high due to regulatory compliance costs.

Private Health Insurance: Your 2026 Options for Coverage

While Medicare offers no subsidy for the medication, private health insurance may help. Here's what changed in 2025–2026:

"Non-PBS Pharmaceuticals" Coverage

Many extras policies include a "non-PBS pharmaceuticals" category that can reimburse medicinal cannabis costs. However, coverage varies significantly by provider:

Top Funds Offering Coverage in 2026

• Bupa: Up to $500/year for non-PBS pharmaceuticals (requires TGA registration)
• Medibank: Extras Gold/Platinum tiers offer $600–$1,200 annual limits for non-PBS meds
• AHM: Comprehensive policies cover up to $800/year for cannabis prescriptions
• NIB: $400–$1,000 annual benefit depending on tier

Critical Requirements for Claims

To claim on private health insurance in 2026, you must verify:

1. TGA Registration: Your prescription must be registered with the Therapeutic Goods Administration
2. ARTG Listing: The product should ideally be on the Australian Register of Therapeutic Goods (though SAS products can sometimes be claimed)
3. Doctor Documentation: Proof of medical necessity from your prescriber
4. Policy Waiting Periods: Standard 12-month waiting periods apply for new policies

What's NOT Covered

• Over-the-counter CBD products (pharmacist-only CBD requires a prescription for insurance claims)
• Recreational cannabis products
• Products not prescribed by an Australian-registered medical practitioner

Retail Availability: Chemist Warehouse and Other Dispensers in 2026

Where can you actually get your prescription filled? This is a common question that competitors gloss over.

Chemist Warehouse Stock Status (2026)

Yes, but with limitations: Chemist Warehouse stocks some medicinal cannabis products in 2026, but:

• Not all stores: Only select metropolitan branches stock pharmaceutical-grade medicinal cannabis
• Prescription required: You cannot purchase medicinal cannabis over the counter
• Stock varies: Availability depends on state regulations and specific product approval
• Pricing: Typically 10–20% higher than specialist medical cannabis pharmacies

Alternative Dispensing Options

Better options often include:

• Specialist Medical Cannabis Pharmacies: Chains like CannaCentre, Medicann, and state-specific providers often have better stock and pricing ($10–$30 savings)
• Online Pharmacies: TGA-approved online dispensers deliver nationwide (check your state's mailing regulations)
• Hospital Pharmacies: For complex cases, major teaching hospitals may compound custom formulations

Pharmacist-Only CBD (No Prescription Needed)

In 2026, low-dose CBD (≤300mg) is available as a pharmacist-only medication in most states. You can purchase this at Chemist Warehouse and other major pharmacies without a prescription, but:

• Not covered by insurance: These are considered supplements, not prescription medicines
• Cost: $40–$80 per bottle
• Limitations: Only CBD, no THC content

State-by-State Access Updates: 2026 Regulations

While federal law permits medicinal cannabis nationwide, state regulations create variation in access and pricing:

State/Territory	2026 Access Status	Notes
NSW	Full access	Authorised Prescribers active; PBS trials ongoing for epilepsy
VIC	Full access	State-run dispensary program expanded in 2025
QLD	Full access	Queensland Health subsidises some products for children with epilepsy
WA	Restricted	TGA approval required for most products; higher costs
S.A.	Full access	Specialist clinics available in Adelaide
TAS	Full access	Local production available; lower costs
A.C.T.	Full access	Recreational use legal; medicinal pathways streamlined
NT	Restricted	TGA approval required; limited retail options

Frequently Asked Questions (FAQs)

Can you claim medical cannabis on Medicare?

No. While Medicare covers your doctor's consultation (providing a rebate of $35–$85 depending on the provider), it does not subsidise the cost of medicinal cannabis itself. The medication is excluded from the Pharmaceutical Benefits Scheme (PBS), meaning you pay the full market price.

Does Chemist Warehouse have medical cannabis?

Yes, but selectively. In 2026, Chemist Warehouse stocks pharmaceutical-grade medicinal cannabis at select metropolitan locations, though availability varies by state. You must have a valid prescription from an Australian-registered medical practitioner. Pharmacist-only CBD products (≤300mg) are widely available without prescription.

What health insurance covers medical cannabis?

Major Australian health funds with "non-PBS pharmaceuticals" coverage may partially reimburse medicinal cannabis costs. In 2026, Bupa, Medibank, AHM, and NIB offer coverage ranging from $400–$1,200 annually, subject to waiting periods and TGA registration requirements. Always check your specific policy before purchasing.

Does Chemist Warehouse stock CBD?

Yes. Chemist Warehouse stocks both prescription-only medicinal cannabis (THC-containing products) and pharmacist-only CBD (low-dose, no prescription required). CBD products under 300mg can be purchased over the counter at $40–$80, while prescription products require a doctor's script and cost $150–$600 monthly.

Why doesn't the government subsidise medicinal cannabis?

As of 2026, the Pharmaceutical Benefits Advisory Committee (PBAC) has not recommended broad PBS listing due to ongoing evaluation of clinical evidence and cost-effectiveness compared to existing treatments. However, targeted PBS trials for specific conditions like Dravet syndrome and chemotherapy-induced nausea continue, with potential broader access expected by late 2026 or 2027.

Are there any state subsidies available?

Some states offer limited subsidies: Queensland subsidises medicinal cannabis for children with refractory epilepsy, and Victoria has expanded its state-run dispensary program. However, these are rare exceptions — most Australian patients pay full price.

How much does medicinal cannabis cost in 2026?

Typical monthly costs range from $80–$400 depending on the product type, dosage, and prescribing pathway. Pharmaceutical-grade products cost $200–$600 monthly, while SAS (Special Access Scheme) products average $150–$400. Pharmacist-only CBD costs $60–$120 monthly.

Disclaimer: This information is current as of April 2026. Regulations and pricing change frequently. Consult with a registered healthcare provider and verify costs with your insurance provider before purchasing.